ENZO BIOCHEM INC Quarterly Common Stock, Shares Authorized from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Enzo Biochem Inc quarterly Common Stock, Shares Authorized history and growth rate from Q2 2011 to Q1 2024.
  • Enzo Biochem Inc Common Stock, Shares Authorized for the quarter ending April 30, 2024 was 75M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 75M 0 0% Apr 30, 2024 10-Q 2024-06-13
Q4 2023 75M 0 0% Jan 31, 2024 10-Q 2024-03-13
Q3 2023 75M 0 0% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 75M 0 0% Jul 31, 2023 10-Q 2024-06-13
Q1 2023 75M 0 0% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 75M 0 0% Jan 31, 2023 10-Q 2023-03-20
Q3 2022 75M 0 0% Oct 31, 2022 10-Q 2022-12-12
Q2 2022 75M 0 0% Jul 31, 2022 10-K 2023-11-03
Q1 2022 75M 0 0% Apr 30, 2022 10-Q 2022-06-09
Q4 2021 75M 0 0% Jan 31, 2022 10-Q 2022-03-14
Q3 2021 75M 0 0% Oct 31, 2021 10-Q 2021-12-15
Q2 2021 75M 0 0% Jul 31, 2021 10-K 2022-10-14
Q1 2021 75M 0 0% Apr 30, 2021 10-Q 2021-06-11
Q4 2020 75M 0 0% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 75M 0 0% Oct 31, 2020 10-Q 2020-12-11
Q2 2020 75M 0 0% Jul 31, 2020 10-K 2021-10-12
Q1 2020 75M 0 0% Apr 30, 2020 10-Q 2020-06-09
Q4 2019 75M 0 0% Jan 31, 2020 10-Q 2020-03-06
Q3 2019 75M 0 0% Oct 31, 2019 10-Q 2019-12-10
Q2 2019 75M 0 0% Jul 31, 2019 10-K 2020-10-19
Q1 2019 75M 0 0% Apr 30, 2019 10-Q 2019-06-10
Q4 2018 75M 0 0% Jan 31, 2019 10-Q 2019-03-11
Q3 2018 75M 0 0% Oct 31, 2018 10-Q 2018-12-10
Q2 2018 75M 0 0% Jul 31, 2018 10-K 2019-10-15
Q1 2018 75M 0 0% Apr 30, 2018 10-Q 2018-06-11
Q4 2017 75M 0 0% Jan 31, 2018 10-Q 2018-03-12
Q3 2017 75M 0 0% Oct 31, 2017 10-Q 2017-12-07
Q2 2017 75M 0 0% Jul 31, 2017 10-K 2018-10-15
Q1 2017 75M 0 0% Apr 30, 2017 10-Q 2017-06-08
Q4 2016 75M 0 0% Jan 31, 2017 10-Q 2017-03-13
Q3 2016 75M 0 0% Oct 31, 2016 10-Q 2016-12-08
Q2 2016 75M 0 0% Jul 31, 2016 10-K 2017-09-27
Q1 2016 75M 0 0% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 75M 0 0% Jan 31, 2016 10-Q 2016-03-09
Q3 2015 75M 0 0% Oct 31, 2015 10-Q 2015-12-08
Q2 2015 75M 0 0% Jul 31, 2015 10-K 2016-10-13
Q1 2015 75M 0 0% Apr 30, 2015 10-Q 2015-06-09
Q4 2014 75M 0 0% Jan 31, 2015 10-Q 2015-03-12
Q3 2014 75M 0 0% Oct 31, 2014 10-Q 2014-12-09
Q2 2014 75M 0 0% Jul 31, 2014 10-K 2015-10-13
Q1 2014 75M 0 0% Apr 30, 2014 10-Q 2014-06-09
Q4 2013 75M 0 0% Jan 31, 2014 10-Q 2014-03-11
Q3 2013 75M 0 0% Oct 31, 2013 10-Q 2013-12-10
Q2 2013 75M 0 0% Jul 31, 2013 10-K 2014-10-09
Q1 2013 75M 0 0% Apr 30, 2013 10-Q 2013-06-10
Q4 2012 75M 0 0% Jan 31, 2013 10-Q 2013-03-12
Q3 2012 75M 0 0% Oct 31, 2012 10-Q 2012-12-10
Q2 2012 75M 0 0% Jul 31, 2012 10-K 2013-10-15
Q1 2012 75M Apr 30, 2012 10-Q 2012-06-11
Q4 2011 75M Jan 31, 2012 10-Q 2012-03-12
Q3 2011 75M Oct 31, 2011 10-Q 2011-12-12
Q2 2011 75M Jul 31, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.